The ACB is committed to dismantling inequalities in the food and agriculture systems in Africa and the promotion of agro-ecology and food sovereignty.

BT- Maize 11 x GA 21 Syngenta

1 . On the 28 March 2006, Syngenta Co, advertised in the Sowetan, its intention to seek approval from the South African National Department of Agriculture (NDA) it will seek approval for the following:

(a) A commodity clearance approval which will enable the import into South
Africa, of stacked GM maize events, Bt11x GA21; and

(b) Approval to enable it to conduct field trials of stacked GM event
Bt11xGA21, in the following areas in South Africa: Brits, Delmas, Greytown,
Klerksdrop, and Potchefstroom.

read more

The status of Genetically Modified (GM) pharmaceutical crop research in South Africa

Genetically modified (GM) pharmaceutical crops are crops which have been genetically engineered / modified to produce pharmaceuticals. These pharmaceuticals can be vaccines, anti-bodies or therapeutic proteins. Pharma-crops (as they are known) are a contested and little-known terrain, with remarkable benefits beingclaimed for them in South Africa. Other voices ask about the contamination of the food supply and the environment, and the social costs of this technology. Following our own research into on the issue the African Centre for Biosafety (ACB) contends that further research is needed into potential risks to human health and the food chain, and that the outcomes of this need to be kept in the public domain.

read more

South Africa – GM Food Labelling Regulations

Why Do We Need To Label Genetically Modified (gm) Food Products?
Facts For South African Consumers
African Centre for Biosafety, Feb 2006

read more

Critical Analysis Of South Africa‘s Labelling Regulations For Genetically Modified Food, Feed And Products Derived From Gm-fed Animals
Mariam Mayet, Oct 2004

read more

Regulations Relating To The Labelling Of Foodstuffs Obtained Through Certain Techniques Of Genetic Modification
Jan 2004

read more

South Africans support international GM opposition day

Earthlife Africa (ELA) and the African Centre for Biosafety (ACB) are joining an international day of action on genetically modified organisms (GMOs) on Saturday the 8th of April, in demanding that GM food for sale in South Africa is labeled as such. Currently, South Africa‘s labeling regulations do not require the mandatory labeling of GM foodstuff, thereby denying consumers the right to know what they are eating and to avoid GM food if they so wish.

read more

The Long, winding road to a Biosafety Protocol – a South African view

At the negotiations for the Biosafety Protocol in Cartagena, the South Africa government surprised critics by displaying a maturity and understanding of the issues and concerns facing developing countries on the question of genetically engineered organisms; This in spite of attempts by the ‘Miami group’, a negotiating group representing the largest producer nations of biotechnology, to significantly weaken the Protocol during its negotiation phase.

read more

Out of Africa: Mysteries of access and benefit sharing

In late 2005 the Edmunds Institute and the African Centre for Biosafety contacted famed bio-pirate hunter Jay McGowan to investigate incidences of access and benefit sharing in Africa. Despite many constraints on the research, McGowan found a plethora of incidents where transnational corporations had utilised African biodiversity without concluding benefit sharing agreements with the local communities or countries they had acquired them from. In a personal note attached to his report, McGowan concluded:

‘It’s a free-for-all out there, and until the parties to the Convention on Biological Diversity (CBD) solve the problems of access and benefit sharing, the robbery will continue. They’ve got to declare a moratorium on access until a just protocol on access and benefit sharing is finished and implemented?until that work is done, the bio-pirates will keep on shouting in the ears of their victims, ?There’s no such thing as biopiracy!?’

read more

Biohazard Map of GM Field Trials in SA

Now that the dust is settling after industry’s aggressive PR hype about the unsubstantiated increase in South Africa’s GM commercial plantings for 2006, we bring to you, based upon empirical data, a short briefing paper on the field trials of GMOs grown in South Africa during 2006, compiled by ACB researcher, Rose Williams. This briefing paper is a precursor to a biohazard map we have compiled of the field trials for 2006, spread wide across our country, following on from the precedent set by Greenpeace India. This is now available on the ACB website:

The ACB has long held the position that the ISAAA obtains its figures of GM commercial plantings directly from the mouths of the seed companies operating in South Africa, who have an interest in painting a rosy picture of an utterly contested technology.

Industry’s PR has obfuscated important issues such as the impact of the higher price of maize and South Africa’s biofuels policy (conversion of maize to ethanol) on maize production in South Africa and absurdly attributing that to consumer acceptance; the moratorium in South Africa on new GM varieties and concomitant aggressive marketing by industry; and most importantly that South Africa has

Bt-Maize 1507 x 59122 x NK 603 / Dow Agrosciences

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB)
OBJECTION TO APPLICATION BY DOW AGROSCIENCES TRIPLE STACKED GM MAIZE, EVENTS, 1507 x NK603 x 59199.

African Centre for Biosafety, Jan 2006

read more
OVERVIEW

The African Centre for Biosafety (ACB) has to date, lodged objections to the following applications by Dow Agrosciences for commodity import clearance:

GM Maize event 59122
GM Maize event 59122xTC 1507
– GM Maize event 59122x NK603

We will thus not repeat the grounds upon which we have based our comprehensive objections, but reiterate them here, and request that the Executive Council take these into account in considering this application. For more details on those three GM maize events read the respective pages on this web site.

FURTHER GROUNDS FOR OUT OF HAND REJECTION

  • GM 59122 NOT YET APPROVED IN USA/NOT BEING GROWN IN USA

    We are utterly amazed that Dow Agrosciences is persisting in seeking regulatory approval for the current GM maize event 1507x 59122 x NK 603, in the light that the cry genes Bt Cry34Ab1/Cry35Ab1 used in event 59122 have not yet been registered by the Environment Protection Authority in the USA. According to information

Roundup Ready Flex Cotton / Monsanto

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB)

OBJECTION TO MONSANTO’S APPLICATION FOR GENERAL RELEASE OF GM COTTON RR FLEX
African Centre for Biosafety, Dec 2005

read more
Summary

The application is for a general release permit to allow the commercial sale and growing of a new transformation event MON88913, also known as Roundup Ready Flex cotton. The new RR Flex variety ostensibly provides increased tolerance to glyphosate compared to the current product, Roundup Ready cotton line 1445. Use of MON 88913 will enable the application of Roundup agricultural herbicide over the top of the cotton crop at later stages of development than is possible with line 1445. Monsanto intends to release the new variety, RR Flex during October/November 2006, in Mpumalanga/Limpopo provinces, and will include both irrigated and dryland cotton plantings.

1. The notifier claims that there are no wild relatives of cotton in South Africa (5.5 of the application). It has come to our attention that this is not the case and we have a concern that we have been misled by the notifier’s claims in this regard. There are about 39 species of Gossypium. They are found worldwide in the tropics and warm

Bt-Maize MON89034 and MON89597 / Monsanto

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB)
  • Objections To The Application Made By Monsanto South Africa For A Permit For A Trial Release Of Mon89034 And Mon89597
    African Centre for Biosafety, 01 Oct 2005
OVERVIEW
DEVELOPER (MONSANTO) APPLICATION: AVAILABLE INFORMATION

The dossier supplied by Monsanto is designated Non Confidential Business Information (Non-CBI). Any response to developers of genetically modified foods is based on a system of gathering information from several sources. This includes engaging scientists and individuals that have similar concerns regarding the introduction of genetically modified foods and who keep track of the different events. Further it includes accessing online government resources of different countries to monitor applications and their progress in those countries and also accessing developer and other web sites (consumer groups, farmers, environmental organisations) to gather information on the events in question. On the basis of this information and coupled with our understanding of the South African situation and legislation a response is formulated to the developer highlighting our concerns. It is instructive that a search on the internet across several search engines for both these events has not yielded a single result. Further, none of the individuals or organisations whom we